Literature DB >> 6734043

Relationship between caffeine concentrations in plasma and saliva.

E Zylber-Katz, L Granit, M Levy.   

Abstract

Caffeine concentrations in plasma and saliva were measured by HPLC in 12 healthy subjects after a single oral dose of 250 to 350 mg. There was a linear relationship between caffeine concentrations in the two fluids. Mean (+/- SE) saliva: total plasma concentration ratio was 0.79 +/- 0.02, while the ratio of the free (non-protein bound):total concentration of drug in plasma was 0.59 +/- 0.01. We postulate that the higher saliva:total plasma ratio as compared to the plasma free: total ratio is a result of pH partitioning. The mean elimination t 1/2 estimated from plasma and saliva concentration-time curves were much the same (5.7 +/- 0.7 and 5.9 +/- 0.8 hr). Values for total body clearance and apparent volume of distribution obtained from saliva data were higher than values derived from plasma concentrations. These differences could be corrected by multiplying the saliva-derived parameters by the saliva: total plasma concentration ratio. We conclude that saliva sampling could serve as a useful technique for therapeutic drug monitoring as well as for research of caffeine kinetics when many samples are required.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734043     DOI: 10.1038/clpt.1984.151

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  15 in total

1.  Cortisol responses to mental stress, exercise, and meals following caffeine intake in men and women.

Authors:  William R Lovallo; Noha H Farag; Andrea S Vincent; Terrie L Thomas; Michael F Wilson
Journal:  Pharmacol Biochem Behav       Date:  2006-05-02       Impact factor: 3.533

Review 2.  Alternative Sampling Strategies for Cytochrome P450 Phenotyping.

Authors:  Pieter M M De Kesel; Willy E Lambert; Christophe P Stove
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

3.  Rapid and sensitive gas-chromatographic determination of caffeine in blood plasma, saliva, and xanthine beverages.

Authors:  H W Teeuwen; E L Elbers; J M van Rossum
Journal:  Mol Biol Rep       Date:  1991-02       Impact factor: 2.316

4.  Characterization of trotter horses urine metabolome by means of proton nuclear magnetic resonance spectroscopy.

Authors:  Chenglin Zhu; Vanessa Faillace; Fulvio Laus; Marilena Bazzano; Luca Laghi
Journal:  Metabolomics       Date:  2018-08-03       Impact factor: 4.290

5.  Self-report reliability and symptomatology of habitual caffeine consumption.

Authors:  J E James; M S Bruce; M H Lader; N R Scott
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

6.  The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.

Authors:  N R Scott; D Stambuk; J Chakraborty; V Marks; M Y Morgan
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

7.  A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants.

Authors:  Laura Hutchinson; Marlene Sinclair; Bernadette Reid; Kathryn Burnett; Bridgeen Callan
Journal:  Br J Clin Pharmacol       Date:  2018-03-25       Impact factor: 4.335

Review 8.  Clinically significant pharmacokinetic interactions between dietary caffeine and medications.

Authors:  J A Carrillo; J Benitez
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

9.  Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man.

Authors:  U Fuhr; K Klittich; A H Staib
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

10.  The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects.

Authors:  M Bruce; N Scott; M Lader; V Marks
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.